Schedule 13G ownership disclosure
LUMOS PHARMA INC
Security class unavailable · CUSIP: 55028X109
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 744,513
- Percent of class
- 9.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-24-005565
- Form type
- SC 13G
- Filer
- LUMOS PHARMA, INC.
- CIK
- CIK 1126234
- Filed
- Nov 12, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership